Aberdeen Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-295,811
| Closed | -$8.92M | – | 940 |
|
|
2024
Q2 | $8.92M | Sell |
295,811
-212,438
| -42% | -$6.41M | 0.02% | 531 |
|
|
2024
Q1 | $17.1M | Sell |
508,249
-24,940
| -5% | -$837K | 0.03% | 436 |
|
|
2023
Q4 | $17.2M | Sell |
533,189
-48,455
| -8% | -$1.57M | 0.04% | 426 |
|
|
2023
Q3 | $19.1M | Sell |
581,644
-62,604
| -10% | -$2.05M | 0.05% | 329 |
|
|
2023
Q2 | $22.7M | Buy |
644,248
+14,588
| +2% | +$513K | 0.05% | 319 |
|
|
2023
Q1 | $20.6M | Sell |
629,660
-61,074
| -9% | -$1.99M | 0.05% | 343 |
|
|
2022
Q4 | $38.1M | Buy |
+690,734
| New | +$38.1M | 0.1% | 213 |
|